logo

Regeneron Saratoga Springs Facility Redevelopment

Sector: Manufacturing (Industrial) • Location: Saratoga Springs, New York, United States

Source: Site Selection Magazine

Project
Planned

Regeneron Pharmaceuticals is investing $2 billion to redevelop the former Quad Graphics magazine printing factory site in Saratoga Springs, New York, into a drug manufacturing facility for infectious diseases and cancer. The project will create 1,000 new jobs and is supported by up to $35 million in performance-based Excelsior Jobs Program tax credits.

Status
Prospective
Sector
Manufacturing (Industrial), Government
Location
Saratoga Springs, New York, United States of America
Updated
22 Jul 2026
Source
Site Selection Magazine

ConstructChat

Ask ConstructChat about Regeneron Saratoga Springs Facility Redevelopment

Pick a question to edit it, or write your own.

First answer free · no account

I am a

Project Information FAQ

Project Information

5 Q
The project “Regeneron Saratoga Springs Facility Redevelopment” is an infrastructure initiative in the Manufacturing (Industrial) sector, located in Saratoga Springs, New York, United States. Taiyo aggregates data on it from Site Selection Magazine.

Participants

Sponsoring Agency

Status

Original status

planned

Taiyo status

Prospective

Taiyo last update

2026-07-22

Contact

Not available for this record.

Description

Description

Regeneron Pharmaceuticals is investing $2 billion to redevelop the former Quad Graphics magazine printing factory site in Saratoga Springs, New York, into a drug manufacturing facility for infectious diseases and cancer. The project will create 1,000 new jobs and is supported by up to $35 million in performance-based Excelsior Jobs Program tax credits.

Original sector

Pharmaceuticals

Budget

Location

Country

United States of America (USA)

State

New York

City

Saratoga Springs

Source

Source

Site Selection Magazine

URL

More Details

Record type

Project

Sector

Manufacturing (Industrial), Government

Article published date

2025-12-04

More on this project

Research

Free account

View all details

You are reading the public part. A free account opens the rest:

  • Every detail on this project
  • News and media coverage
  • Technical research
View all details

Free account · no card · lands you back on this project